The former shareholders of PolyCine GmbH, Mr Thomas Nicola and Mr Martin Schmidtlein agreed to sell their stakes in the Company to Munich-based industrial holding Armira. The parties agreed not to disclose any details of the transaction.
PolyCine is one of the world`s leading suppliers of flexible packaging solutions for the pharmaceutical industry representing excellent quality and extensive technical expertise combined with the highest degree of innovation. Since its foundation by Thomas Nicola and Martin Schmidtlein in 2002, the company has continuously invested in its production site and currently employs over 70 in Schiffweiler and China. This step now will strengthen PolyCine`s successful positioning as a reliable, international partner in the fields of technology and innovation – a positioning we will continue to develop for the benefit of our clients. The new owners of the company share our focus on growth as well as strategic expansion with the aim to carry on PolyCine`s success story.
Rene Gross, Managing Director already since 2014, and Christian Kunz, authorized representative and head of sales, will both continue to manage the business going forward.
PolyCine GmbH in Schiffweiler, Germany, is a specialist in the development and manufacturing of PP-based packaging systems for medical solutions such as sodium chloride, amino acid solutions, lipid solutions etc. Their products also comprise a broad range of patented high gas barrier films for special solutions like antibiotics and vitamin solutions, peel seal films for multi-chamber bags and flat films for drainage bags. Since 2002, the company has distinguished itself by highest standards of quality and innovation.
Armira is an industrial holding company focusing on direct equity investments in privately-held, medium-sized "Mittelstand" businesses in Germany, Austria and Switzerland. Armira engages in established, profitable companies typically generating up to EUR 500m in sales.